人血清蛋白C4b结合蛋白抑制胰腺IAPP诱导的炎症小体活化
研究探讨C4b结合蛋白(C4BP)对胰岛淀粉样多肽(IAPP)诱导的炎症小体活化和IL-1β产生的影响。体外实验显示C4BP以剂量依赖方式抑制IAPP介导的巨噬细胞IL-1β分泌,并保护β细胞功能与活力;人和小鼠胰岛中淀粉样沉积与巨噬细胞浸润相关,人胰岛表达并分泌C4BP且受IL-1β上调。作者提出C4BP作为细胞外伴侣蛋白限制IAPP的促炎效应。
要点
- C4BP在生理浓度下以剂量依赖方式抑制IAPP介导的巨噬细胞IL-1β分泌。
- C4BP与IAPP结合并被内化,抑制IAPP形成淀粉样纤维,并抑制IAPP诱导的吞噬溶酶体完整性丧失。
- 人和小鼠胰岛中淀粉样沉积与更多巨噬细胞浸润相关;人胰岛表达并分泌C4BP,加入IL-1β后增加。
核心结论
- IAPP沉积与胰岛内炎症细胞浸润相关。
- C4BP通过防止巨噬细胞吞噬溶酶体完整性丧失(NLRP3活化所需)来阻断IAPP诱导的炎症小体活化,从而保护β细胞功能与活力。
- C4BP由人胰岛直接分泌,并在炎症细胞因子作用下增加;作者提出C4BP作为细胞外伴侣蛋白限制IAPP的促炎效应。
研究设计与样本
- 体外研究:巨噬细胞暴露于IAPP(加或不加血浆纯化人C4BP),用ELISA和报告细胞系检测IL-1β分泌评估炎症小体活化。
- 用硫黄素T法评估IAPP纤维化;用流式细胞术和共聚焦显微镜评估IAPP-C4BP复合物摄取及对吞噬溶酶体稳定性的影响。
- 用克隆大鼠β细胞系评估C4BP调控IAPP介导炎症小体活化对β细胞功能的影响;用免疫组化检查人和小鼠胰岛中IAPP淀粉样沉积与巨噬细胞浸润的关联;用定量PCR、免疫组化和蛋白质印迹评估人胰岛C4BP表达。
主要发现
- C4BP在生理浓度下以剂量依赖方式显著抑制致敏巨噬细胞中IAPP介导的IL-1β分泌。
- C4BP与IAPP结合并一同内化;C4BP不影响IAPP进入吞噬溶酶体,但抑制其形成淀粉样纤维。
- C4BP共孵育抑制IAPP孵育诱导的巨噬细胞吞噬溶酶体完整性丧失。
- IAPP活化的巨噬细胞上清以IL-1β依赖方式抑制克隆β细胞胰岛素分泌和活力,而巨噬细胞IAPP孵育时加入C4BP可挽救β细胞功能与活力。
- 人和小鼠胰岛中淀粉样沉积的存在与更多浸润巨噬细胞相关;分离的人胰岛表达并分泌C4BP,加入IL-1β后增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Inflammasome activation and subsequent IL-1β production is a driver of islet pathology in type 2 diabetes. Oligomers, but not mature amyloid fibrils, of human islet amyloid polypeptide (IAPP), which is co-secreted with insulin, trigger NOD-like receptor pyrin domain containing-3 (NLRP3) inflammasome activation. C4b-binding protein (C4BP), present in serum, binds to IAPP and affects transition of IAPP monomers and oligomers to amyloid fibrils. We therefore hypothesised that C4BP inhibits IAPP-mediated inflammasome activation and IL-1β production. METHODS: Macrophages were exposed to IAPP in the presence or absence of plasma-purified human C4BP, and inflammasome activation was assessed by IL-1β secretion as detected by ELISA and reporter cell lines. IAPP fibrillation was assessed by thioflavin T assay. Uptake of IAPP-C4BP complexes and their effects on phagolysosomal stability were assessed by flow cytometry and confocal microscopy. The effect of C4BP regulation of IAPP-mediated inflammasome activation on beta cell function was assessed using a clonal rat beta cell line. Immunohistochemistry was used to examine the association of IAPP amyloid deposits and macrophage infiltration in isolated human and mouse pancreatic islets, and expression of C4BP from isolated human pancreatic islets was assessed by quantitative PCR, immunohistochemistry and western blot. RESULTS: C4BP significantly inhibited IAPP-mediated IL-1β secretion from primed macrophages at physiological concentrations in a dose-dependent manner. C4BP bound to and was internalised together with IAPP. C4BP did not affect IAPP uptake into phagolysosomal compartments, although it did inhibit its formation into amyloid fibrils. The loss of macrophage phagolysosomal integrity induced by IAPP incubation was inhibited by co-incubation with C4BP. Supernatant fractions from macrophages activated with IAPP inhibited both insulin secretion and viability of clonal beta cells in an IL-1β-dependent manner but the presence of C4BP during macrophage IAPP incubation rescued beta cell function and viability. In human and mouse islets, the presence of amyloid deposits correlated with higher numbers of infiltrating macrophages. Isolated human islets expressed and secreted C4BP, which increased with addition of IL-1β. CONCLUSIONS/INTERPRETATION: IAPP deposition is associated with inflammatory cell infiltrates in pancreatic islets. C4BP blocks IAPP-induced inflammasome activation by preventing the loss of macrophage phagolysosomal integrity required for NLRP3 activation. The consequence of this is the preservation of beta cell function and viability. C4BP is secreted directly from human pancreatic islets and this increases in response to inflammatory cytokines. We therefore propose that C4BP acts as an extracellular chaperone protein that limits the proinflammatory effects of IAPP.
引用
- Kulak K, Westermark GT, Papac-Milicevic N, et al. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation. Diabetologia. 2017. PMID: 28500395. doi:10.1007/s00125-017-4286-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。